PRS-220

N/A

Report date: 2024/12/19 11:48:53

Base Information

Drug NamePRS-220
Drug Alias NamePRS-220
ClassificationBiologics > Protein drugs
Mechanisms of ActionConnective tissue growth factor inhibitors
TargetsConnective tissue growth factor
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPieris Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesPieris Australia Pty Ltd
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A